Ashland

Viatel™ Ultrapure polymers: High-purity, controlled-release polymers for improved consistency and extended durations in long-acting injectables and implants (LAII). With a proprietary purification process, residual monomer is reduced to <0.5%, ensuring reproducible performance and a more neutral pH environment. These GMP-grade polymers, with typical batch results of 0.1% monomer content, offer formulators greater versatility in addressing complex formulation challenges, reflecting Ashland's commitment to continuous improvement in response to customer needs.

Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment.

Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.

Leila Giarola, a scientist at Ashland Specialty Ingredients, presented the company’s poster Evaluation of a Novel Titanium-Free Film Coating Formulation with Whiter, Brighter and Glossier Finish at AAPS 2021 PharmSci 360.

Learn how to evaluate excipients for continuous manufacturing in a rational fashion. This webcast will demonstrate the importance of collaboration between pharmaceutical scientists and excipient suppliers as the industry continues its quest to optimize manufacturing processes for cost and scale efficiencies. Live: Thursday, Sept. 26, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Sept. 26, 2020 Register free